Nature Communications (Feb 2020)

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

  • Elena Galvani,
  • Piyushkumar A. Mundra,
  • Sara Valpione,
  • Pablo Garcia-Martinez,
  • Matthew Smith,
  • Jonathan Greenall,
  • Rohit Thakur,
  • Beth Helmink,
  • Miles C. Andrews,
  • Louis Boon,
  • Christopher Chester,
  • Gabriela Gremel,
  • Kate Hogan,
  • Amit Mandal,
  • Kang Zeng,
  • Antonia Banyard,
  • Garry Ashton,
  • Martin Cook,
  • Paul Lorigan,
  • Jennifer A. Wargo,
  • Nathalie Dhomen,
  • Richard Marais

DOI
https://doi.org/10.1038/s41467-020-14632-2
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 9

Abstract

Read online

Identification of clinical relevant biomarkers to predict response to immune checkpoint blockade (ICB) in melanoma remains challenging. Here, the authors show that stroma remodelling and reduced cell division are associated with durable response to anti-PD1 in a mouse model of melanoma and in ICB-treated patients.